Joseph Bratica

SRPT

PRINCIPAL FINANCIAL OFFICER · SAREPTA THERAPEUTICS, INC. · CIK 0001820070

FILING MIX · LIFETIME33%/67%

BUYS

SELLS

TOTAL VALUE

$684.6K

COMPANIES

ACTIVE SINCE

Aug 2020

HOLDINGS NOW

12,285

AVG SELL PX

$159.99

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

3 backtested trades · 8 horizons

Forward-return performance of every backtestable P/S trade by Joseph Bratica, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	3	+0.00%	+4.16%	+1.04%	+3.12%	+3.66%	—
14d	3	+0.00%	+6.32%	+1.19%	+5.13%	+3.49%	—
30d	3	+66.67%	-16.48%	+5.16%	-21.63%	-19.63%	—
60d	3	+100.00%	-32.67%	+4.71%	-37.38%	-44.10%	—
90d	3	+100.00%	-36.02%	+4.10%	-40.11%	-50.50%	—
180d	3	+100.00%	-47.76%	+14.79%	-62.56%	-64.16%	—
1y	3	+100.00%	-50.13%	+31.71%	-81.84%	-79.20%	—
2y	3	+100.00%	-30.17%	+17.36%	-47.53%	-39.47%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

SRPT · 12,285 shares · as of Dec 11, 2020

Trading cadence · quarterly flow

BUY ● SELL ●

2020

FLOW · 3 buys / 6 sellsCOVERAGE · 2 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED
SRPT SAREPTA THERAPEUTICS, INC.	PURCHASE Principal Financial Officer	1,115	$71.45	$79.7K	9,255	Dec 11, 2020	Dec 14, 2020 ↗
SRPT SAREPTA THERAPEUTICS, INC.	SALE Principal Financial Officer	1,115	$165.00	$184.0K	8,140	Dec 11, 2020	Dec 14, 2020 ↗
SRPT SAREPTA THERAPEUTICS, INC.	SALE Principal Financial Officer	1,115	—	—	12,285	Dec 11, 2020	Dec 14, 2020 ↗
SRPT SAREPTA THERAPEUTICS, INC.	PURCHASE Principal Financial Officer	1,125	$29.60	$33.3K	9,265	Dec 8, 2020	Dec 10, 2020 ↗
SRPT SAREPTA THERAPEUTICS, INC.	SALE Principal Financial Officer	1,125	$160.00	$180.0K	8,140	Dec 8, 2020	Dec 10, 2020 ↗
SRPT SAREPTA THERAPEUTICS, INC.	SALE Principal Financial Officer	1,125	—	—	4,500	Dec 8, 2020	Dec 10, 2020 ↗
SRPT SAREPTA THERAPEUTICS, INC.	PURCHASE Principal Financial Officer	1,125	$29.60	$33.3K	8,957	Aug 3, 2020	Aug 5, 2020 ↗
SRPT SAREPTA THERAPEUTICS, INC.	SALE Principal Financial Officer	1,125	$155.00	$174.4K	7,832	Aug 3, 2020	Aug 5, 2020 ↗
SRPT SAREPTA THERAPEUTICS, INC.	SALE Principal Financial Officer	1,125	—	—	5,625	Aug 3, 2020	Aug 5, 2020 ↗

Other insiders · SRPT

Loading peer insiders…

About this filer

CIK 0001820070

ROLE

Principal Financial Officer

PRIMARY

SRPT

COMPANIES

ACTIVE SINCE

Aug 2020

MARKETPEEL · /INSIDER/0001820070DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Joseph Bratica

The morning brief, before the bell.